StockData
Nanobiotix S.A. logo

Nanobiotix S.A. (NBTX) stock

NBTXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as NNBXF
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 3/30
$27.45−1.09 (-3.82%)

Close on Nov 17, 2026Market cap $1.33BP/E –Yield –

Nanobiotix r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2025 it was €23.12M, down 43.0% from the year before. The highest annual figure on record is €40.54M in fiscal 2024.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025€23.12M-43.0%
FY2024Dec 31, 2024€40.54M+5.6%
FY2023Dec 31, 2023€38.40M+17.6%
FY2022Dec 31, 2022€32.64M+7.4%
FY2021Dec 31, 2021€30.38M+24.9%
FY2020Dec 31, 2020€24.33M-20.0%
FY2019Dec 31, 2019€30.41M+45.6%
FY2018Dec 31, 2018€20.89M–

More Nanobiotix figures

See a number that looks wrong?